Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation - 06/09/13
, Françoise Roudot-Thoraval b, Jeanne Tran Van Nhieu c, Calina Atanasiu a, Michael D. Kluger a, Fatiha Medkour a, Catherine Douvin a, Ariane Mallat a, Elie-Serge Zafrani c, Daniel Cherqui a, Christophe Duvoux aBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background |
Liver stiffness measurement (LSM) by transient elastography (TE) (FibroScan®) is a validated method of quantifying liver fibrosis in non-transplanted patients with hepatitis C virus (HCV). It could be useful in follow-up after liver transplantation (LT). The aim of this study was to assess the diagnostic accuracy of LSM in evaluating liver fibrosis after LT in patients with and without recurrent HCV.
Patients and methods |
Forty-three patients (mean age 57.6±9.9 years), 28 (65.1%) HCV-positive patients and 15 (34.9%) HCV-negative patients underwent gold standard liver biopsy and TE 55.8±4.9 months after transplantation. Liver fibrosis was scored on biopsy specimens according to METAVIR (F0-F4). Accuracy of TE and optimal stiffness cut-off values for fibrosis staging were determined by a receiver-operating characteristics (ROC) curve analysis.
Results |
Median stiffness values were significantly different for METAVIR score less than 2 (5.8kPa) vs. METAVIR score greater to equal to 2 (9.6kPa) (P<0.001). The area under the ROC curve was 0.83 for METAVIR score greater to equal to 2 (95%CI: 0.71–0.95). The optimal stiffness cut-off value was 7kPa for METAVIR scores greater to equal to 2. The results were similar whether the patients had recurrent HCV infection or not.
Conclusions |
These results indicate that transient elastography accurately identifies LT recipients with significant fibrosis, irrespective of HCV status. It is a promising non-invasive tool to assess graft fibrosis progression after LT in patients with HCV recurrence, as well as for screening of late graft fibrosis of other etiologies. Transient elastography could reduce the use of invasive protocol biopsies.
Le texte complet de cet article est disponible en PDF.Abbreviations : HCC, HCV, IQR, kPa, LSM, LT, ROC, TE
Plan
Vol 37 - N° 4
P. 347-352 - septembre 2013 Retour au numéro
Article précédent
- Hepatitis C virus infection in hemodialysis patients
- Anais Vallet-Pichard, Stanislas Pol
- Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD)
- Federica Scaglioni, Mariano Marino, Stefania Ciccia, Alessia Procaccini, M. Busacchi, Paola Loria, Amedeo Lonardo, Marcella Malavolti, Nino Carlo Battistini, Massimo Pellegrini, Francesca Carubbi, Stefano Bellentani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?